Back
Galmed Pharmaceuticals Stock Price Chart
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Buy
63
GLMD
Galmed Pharmaceuticals
Last Price:
8.13
Seasonality Move:
-17.74%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLMD is experiencing selling pressure, which indicates risk of future bearish movement.
Galmed Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.55 | Buy |
| 20-day SMA: | 4.33 | Buy |
| 50-day SMA: | 3.9 | Buy |
| 200-day SMA: | 4.3 | Buy |
| 8-day EMA: | 6.37 | Buy |
| 20-day EMA: | 4.89 | Buy |
| 50-day EMA: | 4.21 | Buy |
| 200-day EMA: | 8.49 | Sell |
Galmed Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1 | Buy |
| Relative Strength Index (14 RSI): | 55.55 | Buy |
| Chaikin Money Flow: | -5448855 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.8 - 6.52) | Buy |
| Bollinger Bands (100): | (2.82 - 5.34) | Buy |
Galmed Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Galmed Pharmaceuticals Stock
Is Galmed Pharmaceuticals Stock a Buy?
- Galmed Pharmaceuticals share price is 6.83 while GLMD 8-day simple moving average is 5.55, which is a Buy signal.
- The stock price of GLMD is 6.83 while Galmed Pharmaceuticals 20-day SMA is 4.33, which makes it a Buy.
- Galmed Pharmaceuticals 50-day simple moving average is 3.90 while GLMD share price is 6.83, making it a Buy technically.
- GLMD stock price is 6.83 and Galmed Pharmaceuticals 200-day simple moving average is 4.30, creating a Buy signal.
GLMD Technical Analysis vs Fundamental Analysis
Buy
63
Galmed Pharmaceuticals (GLMD)
is a Buy
Is Galmed Pharmaceuticals a Buy or a Sell?
-
Galmed Pharmaceuticals stock is rated a Buy
The current Galmed Pharmaceuticals [GLMD] share price is $6.83. The Score for GLMD is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Galmed Pharmaceuticals Stock Info
Market Cap:
4.4M
Price in USD:
6.83
Share Volume:
6.17M
Galmed Pharmaceuticals 52-Week Range
52-Week High:
23.80
52-Week Low:
2.73
Buy
63
Galmed Pharmaceuticals (GLMD)
is a Buy
Galmed Pharmaceuticals Share Price Forecast
-
What is the Galmed Pharmaceuticals stock price today?
The Galmed Pharmaceuticals stock price is 6.83 USD today. -
Will GLMD stock go up or go down?
Galmed Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Galmed Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Galmed Pharmaceuticals is not overvalued.
Is Galmed Pharmaceuticals Stock a Buy?
- Galmed Pharmaceuticals share price is 6.83 while GLMD 8-day exponential moving average is 6.37, which is a Buy signal.
- The stock price of GLMD is 6.83 while Galmed Pharmaceuticals 20-day EMA is 4.89, which makes it a Buy.
- Galmed Pharmaceuticals 50-day exponential moving average is 4.21 while GLMD share price is 6.83, making it a Buy technically.
- GLMD stock price is 6.83 and Galmed Pharmaceuticals 200-day simple moving average is 8.49, creating a Sell signal.
Fundamental Analysis of Galmed Pharmaceuticals
Is Galmed Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.70 per share, and an increase next year of $0.02 per share.
Technical Analysis of Galmed Pharmaceuticals
Should I short Galmed Pharmaceuticals stock?
- GLMD Moving Average Covergence Divergence (MACD) indicator is 1, suggesting Galmed Pharmaceuticals is a Buy
- Galmed Pharmaceuticals Relative Strength Index (RSI) is 55.55, which suggest Galmed Pharmaceuticals is overbought
- The Bollinger Bands (25) for Galmed Pharmaceuticals is (1.8 - 6.52), which suggest Galmed Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Galmed Pharmaceuticals is (2.82 - 5.34), which suggest Galmed Pharmaceuticals is a Buy
* Galmed Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.